Holen Sie sich die Stockscreener-App
1.32
0.00%
0.00
Handel nachbörslich:
1.32
Tharimmune Inc Aktie (THAR) Neueste Nachrichten
Tharimmune, Inc. SEC 10-Q Report - TradingView
What risks could impact Tharimmune Inc. stock performanceQuarterly Trade Summary & Fast Entry Momentum Trade Alerts - Newser
News impact scoring models applied to Tharimmune Inc.July 2025 Levels & Low Risk Entry Point Guides - Newser
Applying Wyckoff theory to Tharimmune Inc. stockEarnings Growth Report & Safe Capital Growth Tips - Newser
Tharimmune expands IP portfolio for opioid countermeasure technology By Investing.com - Investing.com Australia
What indicators show strength in Tharimmune Inc.July 2025 Breakouts & Smart Money Movement Tracker - Newser
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl - Weatherford Democrat
Military-Grade Fentanyl Protection: Tharimmune's Drug Platform Secures Global Patent Shield Through 2040 - Stock Titan
Using data filters to optimize entry into Tharimmune Inc.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Multi factor analysis applied to Tharimmune Inc.2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
What’s the recovery path for long term holders of Tharimmune Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Using data tools to time your Tharimmune Inc. exit2025 Market Outlook & Momentum Based Trading Signals - Newser
Using data tools to time your Tharimmune Inc. exit [2025 Analyst Calls]AI Driven Price Predictions - Newser
Tharimmune prices $1.74 million direct offering - MSN
Published on: 2025-08-12 04:27:10 - Newser
Chart based analysis of Tharimmune Inc. trendsLong-Term Investment Strategy Impact Analysis - Newser
Tharimmune Inc. stock trend outlook and recovery pathFree High Conviction Intraday Stock Signals - Newser
Using AI based signals to follow Tharimmune Inc.High Return Idea With Technical Filter - Newser
What machine learning models say about Tharimmune Inc.Free Secure Return Focused Investment Plan - Newser
Analyzing drawdowns of Tharimmune Inc. with statistical toolsReal-Time AI Generated Market Forecast - Newser
Using fundamentals and technicals on Tharimmune Inc.Long Term Stock Planner with Safety Checks - Newser
Has Tharimmune Inc. Stock Ever Crashed Historical Volatility ReviewMonthly Trade Result and Signal Summary - Newser
What makes Tharimmune Inc. stock price move sharplyEquity Forecast with Predictive AI Screener - Newser
Tharimmune Appoints Nancy Davis to Board of Directors - The Globe and Mail
Is Tharimmune Inc. showing insider buyingBest Value for High Returns - thegnnews.com
Tharimmune, Inc. Appoints Nancy Davis to Its Board of Directors - MarketScreener
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery - The Florida Times-Union
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors - Corsicana Daily Sun
Race to Erase MS Founder Who Raised $56M Joins Biotech Board to Fight Addiction Crisis - Stock Titan
Watch for Bullish Crossover in Tharimmune Inc.Alpha Driven Watchlist With Alerts Published - beatles.ru
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants - Asbury Park Press
Tharimmune Advances Fentanyl Defense Solution, Breakthrough Oral Antibody Technology | THAR Stock News - Stock Titan
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):